Article ID: CBB665653849

Marketing Masked Depression: Physicians, Pharmaceutical Firms, and the Redefinition of Mood Disorders in the 1960s and 1970s (2016)

unapi

This article investigates the redefinition of depression that took place in the early 1970s. Well before the introduction of the third edition of the Diagnostic and Statistical Manual of Mental Disorders, this rather rare and severe psychiatric disorder hitherto treated in asylums was transformed into a widespread mild mood disorder to be handled by general practitioners. Basing itself on the archives of the Swiss firm Ciba-Geigy, the article investigates the role of the pharmaceutical industry in organizing this shift, with particular attention paid to research and scientific marketing. By analyzing the interplay between the firm, elite psychiatrists specializing in the study of depression, and general practitioners, the article argues that the collective construction of the market for first-generation antidepressants triggered two realignments: first, it bracketed etiological issues with multiple classifications in favor of a unified symptom-oriented approach to diagnosis and treatment; second, it radically weakened the differentiation between antidepressants, neuroleptics, and tranquilizers. The specific construction of masked depression shows how, in the German-speaking context, issues of ambulatory care such as recognition, classification, and treatment of atypical or mild forms of depression were reshaped to meet commercial as well as professional needs.

...More
Citation URI
https://data.isiscb.org/isis/citation/CBB665653849/

Similar Citations

Article Horwitz, Allan V.; (2011)
Naming the Problem That Has No Name: Creating Targets for Standardized Drugs (/isis/citation/CBB001221532/)

Book Shorter, Edward; (2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry (/isis/citation/CBB000952059/)

Book Blazer, Dan G.; (2005)
The Age of Melancholy: “Major Depression” and Its Social Origins (/isis/citation/CBB000600050/)

Article Oded Heilbronner; (2021)
The mentally ill and how they were perceived in young Israel (/isis/citation/CBB520900198/)

Book Martin, Emily; (2007)
Bipolar Expeditions: Mania and Depression in American Culture (/isis/citation/CBB000774183/)

Book Ghaemi, S. Nassir; (2013)
On Depression: Drugs, Diagnosis, and Despair in the Modern World (/isis/citation/CBB001553380/)

Book Lane, Christopher; (2007)
Shyness: How Normal Behavior Became a Sickness (/isis/citation/CBB001210279/)

Book Jonathan Sadowsky; (2020)
The Empire of Depression: A New History (/isis/citation/CBB846402776/)

Article Ingram, Allan; (2006)
Death in Life and Life in Death: Melancholy and the Enlightenment (/isis/citation/CBB000670764/)

Article Onome V. Atigari; Margaret Harris; Joanna Le Noury; David Healy; (2016)
Bipolar Disorder and Its Outcomes: Two Cohorts, 1875–1924 and 1994–2007, Compared (/isis/citation/CBB275166187/)

Book Jean Starobinski; (2012)
L'Encre de la mélancolie (/isis/citation/CBB020822602/)

Book Dowbiggin, Ian Robert; (2011)
The Quest for Mental Health: A Tale of Science, Medicine, Scandal, Sorrow, and Mass Society (/isis/citation/CBB001251120/)

Book Borch-Jacobsen, Mikkel; (2002)
Folies à Plusieurs: De l'hystérie à la dépression (/isis/citation/CBB000201307/)

Authors & Contributors
Healy, David
Molaro, Aurelio
Onome V. Atigari
Heilbronner, Oded
Rector, Claudia A.
Starobinski, Jean
Concepts
Depression
Mental disorders and diseases
Psychiatry
Pharmaceutical industry
Diagnosis
Psychotropic drugs
Time Periods
20th century, late
20th century
21st century
19th century
18th century
17th century
Places
United States
Switzerland
Germany
Israel
Great Britain
Institutions
United States. Food and Drug Administration (USFDA)
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment